Multicenter Clinical Performance Study to evaluate Plasma-based RAS Gene Mutation Testing using OncoBEAM RAS CRC assay (LS52R) of Patients having Progressive or Recurrent Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
Primary outcome(s): Overall percent agreement (OPA) of both KRAS and NRAS gene exon 2, 3 and 4 mutations between Plasma RAS testing and Reference method
创建时间：
2016-07-15
